WELL Health Technologies (WELL) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
4 May, 2026Opening remarks and agenda
Meeting called to order by the chairman, with appointments for secretary, scrutineer, moderator, and legal formalities established.
Rules for virtual meeting conduct and electronic voting procedures were outlined for orderly proceedings.
The agenda was set according to the Management Information Circular dated May 3, 2024.
Corporate governance
Quorum was confirmed, and proof of proper notice and mailing was filed and annexed to the minutes.
The number of directors was set at six, with all nominated directors confirming their willingness to serve.
Election of directors proceeded with no other nominations or questions from shareholders.
Board and executive committee updates
Six directors were nominated and elected to serve until the next annual meeting or until successors are appointed.
Latest events from WELL Health Technologies
- Record Q1-2026 revenue and EBITDA growth driven by Canadian clinics and tech expansion.WELL
Q1 20268 May 2026 - Record Q1-2025 revenue and EBITDA growth, with raised guidance and strong Canadian performance.WELL
Q1 20256 May 2026 - Record Q3 revenue, EBITDA growth, raised 2024 guidance, and robust M&A and tech momentum.WELL
Q3 20244 May 2026 - Record Q2 revenue, raised guidance, and AI-driven strategy fuel strong growth and efficiency.WELL
Q2 20244 May 2026 - Record revenue and 75% net income growth in 2024, with strong 2025 outlook and M&A momentum.WELL
Q4 20244 May 2026 - Record Q2 revenue, EBITDA, and raised guidance driven by growth, M&A, and HEALWELL AI.WELL
Q2 20254 May 2026 - Record revenue and EBITDA growth, robust M&A pipeline, and strong 2026 outlook.WELL
Q4 202520 Mar 2026 - Record Q3 revenue and EBITDA, strong Canadian growth, and robust M&A pipeline for 2025.WELL
Q3 202513 Nov 2025 - WELL Health leverages technology, AI, and capital discipline to drive growth and unlock shareholder value.WELL
Investor Day 2024 Presentation13 Jun 2025